← Leaderboards
Iain Scott
University Of Pittsburgh At Pittsburgh
$7,663,600
Attributed
$7,663,600
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,663,600 · 5
By mechanism
R01$6,462,864 · 3
K22$731,377 · 1
R56$469,359 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Jeremy N Rich$24,023,429
- Teresa Hagan Thomas$3,176,012
- Ulka Sachdev$2,791,526
- Lori N Scott$5,429,857
- Steve A Kay$26,702,111
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMitochondriaMediatingIn VitroPathway InteractionsBiochemicalAcetylationRegulationOutputAcetyltransferaseIn VivoLinkEnzymesHeartFutureCardiacFatty Acid OxidationKnockout MiceHeart FailureMetabolismProductionDefectBioenergeticsMolecular
Grant awards (17)
Fatty acid oxidation in female cardioprotection$528,275
R01 · FY2025 · HL · contact PI
Fatty acid oxidation in female cardioprotection$539,826
R01 · FY2024 · HL · contact PI
Novel strategies to resolve metabolic defects in the diabetic heart$469,377
R01 · FY2024 · HL · contact PI
Fatty acid oxidation in female cardioprotection$550,841
R01 · FY2023 · HL · contact PI
Novel strategies to resolve metabolic defects in the diabetic heart$478,956
R01 · FY2023 · HL · contact PI
Fatty acid oxidation in female cardioprotection$538,256
R01 · FY2022 · HL · contact PI
Novel strategies to resolve metabolic defects in the diabetic heart$478,956
R01 · FY2022 · HL · contact PI
Novel strategies to resolve metabolic defects in the diabetic heart$478,956
R01 · FY2021 · HL · contact PI
Regulation of Fuel Utilization by Lysine Acetylation in the Failing Heart$481,347
R01 · FY2020 · HL · contact PI
Novel strategies to resolve metabolic defects in the diabetic heart$478,956
R01 · FY2020 · HL · contact PI
Regulation of Fuel Utilization by Lysine Acetylation in the Failing Heart$481,347
R01 · FY2019 · HL · contact PI
Regulation of Fuel Utilization by Lysine Acetylation in the Failing Heart$480,590
R01 · FY2018 · HL · contact PI
Regulation of Fuel Utilization by Lysine Acetylation in the Failing Heart$477,181
R01 · FY2017 · HL · contact PI
Regulation of Fuel Utilization by Lysine Acetylation in the Failing Heart$469,359
R56 · FY2016 · HL · contact PI
Regulation of mitochondrial function by a novel lysine acetyltransferase$238,534
K22 · FY2016 · HL · contact PI
Regulation of mitochondrial function by a novel lysine acetyltransferase$243,843
K22 · FY2015 · HL · contact PI
Regulation of mitochondrial function by a novel lysine acetyltransferase$249,000
K22 · FY2014 · HL · contact PI